Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T16:11:32.242Z.
Calculation as of: 2026-10-06T16:11:32.242Z.
Quote observation: 2026-10-06T16:10:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c88c4f39e0f2b8ce509c05ad310ef4a925915372bb385716b1b31bbca6f45484
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$30.89M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.77M
EV/EBITDA Ratio
12.91x
TTM Avg
114.94x
3Y Avg
46.61x
5Y Avg
32.69x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | $30.57M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $30.32M | N/A | N/A | N/A | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.62M | N/A | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.89M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.59M | N/A | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $29.67M | N/A | 0.36x | 0.82x | 0.82x |
| OneMedNet Corporation (ONMD)vs › | $29.66M | N/A | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 12.91x | 114.94x | 46.61x | 32.69x |
| Rockwell Medical, Inc. (RMTI)vs › | $32.60M | N/A | 26.23x | 26.23x | 26.23x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute